Pharma company Pfizer today said its consolidated net profit declined by 54.22 per cent

RELATED ARTICLES Tata Chemicals Q3 net up 36% at Rs 223.78 cr Reliance Communications Q3 net falls 61% MTNL registers Rs 929.77 cr loss in Q3 HPCL's Q3 net profit up 12 fold at Rs 2,725.18 cr Natco Pharma Q3 net profit jumps 24%

to Rs 137 crore for the quarter ended November 30.

It had a net profit of Rs 299.58 crore in the same period last year.

"The net sales for the three months and full year ended November 30, 2009 include sales of products transferred to Johnson & Johnson Ltd. Hence, the figures are not comparable," Pfizer Ltd said in a filing to the Bombay Stock Exchange (BSE).

Net sales stood at Rs 772 crore for the September-November quarter '09, while they were at Rs 681.7 crore in the same period last year, the filing added.

On standalone basis, the company has posted a net profit of Rs 25.73 crore for the quarter ended November 30, 2009. However, it had a net profit of Rs 30.23 crore in the same period last year.

Shares of Pfizer today closed at Rs 931.90 on the BSE, up 0.02 per cent from previous close.